New extension study data with Novartis drug Gilenya shows patients successfully treated for up to 7 years in relapsing MS
Source URL: https://qa1.novartis.us/us-en/news/media-releases/new-extension-study-data-novartis-drug-gilenya-shows-patients-successfully-treated-7-years-relapsing-ms-0
List of links present in page
- https://qa1.novartis.us/us-en/us-en/news/media-releases/new-extension-study-data-novartis-drug-gilenya-shows-patients-successfully-treated-7-years-relapsing-ms-0